Economic burden of hepatitis C-associated diseases in the United States-Reference-Cited by-同舟云学术

Economic burden of hepatitis C-associated diseases in the United States

Published:2011-12-18 Issue:3 Volume:19 Page:153-160
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

El Khoury A. C.,Klimack W. K.,Wallace C.,Razavi H.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2011.01563.x/fullpdf

Reference57 articles.

1. National Institutes of Health Consensus Development Statement: management of hepatitis C: 2002-June 10-12, 2002;National Institutes of Health;Hepatology,2002

2. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010

3. Centers for Disease Control and Prevention Disease Burden from Viral Hepatitis A, B, and C in the United States http://www.cdc.gov/hepatitis/Statistics/index.htm

4. Direct economic burden of chronic hepatitis C virus in a United States managed care population;Davis;J Clin Gastroenterol,2011

5. Projecting future complications of chronic hepatitis C in the United States;Davis;Liver Transpl,2003

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts;Transplantation;2024-09-04

2. HCV infection epidemiology in Thi Qar Province, Southern Iraq, from 2005 to 2021;PHYSICAL MESOMECHANICS OF CONDENSED MATTER: Physical Principles of Multiscale Structure Formation and the Mechanisms of Nonlinear Behavior: MESO2022;2023

3. Prevalence and Risk Factors of hepatitis B and C infections in general population of Tehsil Arifwala;Pakistan BioMedical Journal;2022-06-30

4. Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review;Frontiers in Public Health;2022-04-21

5. Economic burden of chronic viral hepatitis C;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-01-15